754 related articles for article (PubMed ID: 19204509)
1. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
2. Vasoactivity of bovine polymerized hemoglobin (HBOC-201) in swine with traumatic hemorrhagic shock with and without brain injury.
Rice J; Philbin N; Handrigan M; Hall C; McGwin G; Ahlers S; Pearce LB; Arnaud F; McCarron R; Freilich D
J Trauma; 2006 Nov; 61(5):1085-99. PubMed ID: 17099513
[TBL] [Abstract][Full Text] [Related]
3. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.
Jahr JS; Mackenzie C; Pearce LB; Pitman A; Greenburg AG
J Trauma; 2008 Jun; 64(6):1484-97. PubMed ID: 18545113
[TBL] [Abstract][Full Text] [Related]
4. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
Johnson T; Arnaud F; Dong F; Philbin N; Rice J; Asher L; Arrisueno M; Warndorf M; Gurney J; McGwin G; Kaplan L; Flournoy WS; Apple FS; Pearce LB; Ahlers S; McCarron R; Freilich D
Crit Care Med; 2006 May; 34(5):1464-74. PubMed ID: 16540964
[TBL] [Abstract][Full Text] [Related]
5. Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study.
Jahr JS; Liu H; Albert OK; Gull A; Moallempour M; Lim J; Gosselin R
Am J Ther; 2010; 17(2):140-7. PubMed ID: 19417588
[TBL] [Abstract][Full Text] [Related]
6. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
Moore EE; Moore FA; Fabian TC; Bernard AC; Fulda GJ; Hoyt DB; Duane TM; Weireter LJ; Gomez GA; Cipolle MD; Rodman GH; Malangoni MA; Hides GA; Omert LA; Gould SA;
J Am Coll Surg; 2009 Jan; 208(1):1-13. PubMed ID: 19228496
[TBL] [Abstract][Full Text] [Related]
7. Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury.
King DR; Cohn SM; Proctor KG
J Trauma; 2005 Sep; 59(3):553-60; discussion 560-2. PubMed ID: 16361895
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock.
Sampson JB; Davis MR; Mueller DL; Kashyap VS; Jenkins DH; Kerby JD
J Trauma; 2003 Oct; 55(4):747-54. PubMed ID: 14566133
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41).
Dudkiewicz M; Harpaul TA; Proctor KG
Crit Care Med; 2008 Oct; 36(10):2838-48. PubMed ID: 18766094
[TBL] [Abstract][Full Text] [Related]
10. Blood substitutes as pharmacotherapies in clinical practice.
Jahr JS; Walker V; Manoochehri K
Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
[TBL] [Abstract][Full Text] [Related]
11. The effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers in swine with hemorrhagic shock.
Rice J; Philbin N; Light R; Arnaud F; Steinbach T; McGwin G; Collier S; Malkevich N; Moon-Massatt P; Rentko V; Pearce LB; Ahlers S; McCarron R; Handrigan M; Freilich D
J Trauma; 2008 May; 64(5):1240-57. PubMed ID: 18469646
[TBL] [Abstract][Full Text] [Related]
12. Clinical contextualization and the assessment of adverse events in HBOC trials.
Greenburg AG; Pitman A; Pearce B; Kim HW
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):477-86. PubMed ID: 19039687
[TBL] [Abstract][Full Text] [Related]
13. Resuscitation following severe, controlled hemorrhage associated with a 24 h delay to surgical intervention in swine using a hemoglobin based oxygen carrier as an oxygen bridge to definitive care.
Philbin N; Handrigan M; Rice J; McNickle K; McGwin G; Williams R; Warndorf M; Arnaud F; Malkevich N; McCarron R; Freilich D
Resuscitation; 2007 Aug; 74(2):332-43. PubMed ID: 17383073
[TBL] [Abstract][Full Text] [Related]
14. A safety and efficacy evaluation of hemoglobin-based oxygen carrier HBOC-201 in a randomized, multicenter red blood cell controlled trial in noncardiac surgery patients.
Van Hemelrijck J; Levien LJ; Veeckman L; Pitman A; Zafirelis Z; Standl T
Anesth Analg; 2014 Oct; 119(4):766-776. PubMed ID: 24977631
[TBL] [Abstract][Full Text] [Related]
15. Severe adverse events associated with hemoglobin based oxygen carriers: role of resuscitative fluids and liquid preserved RBC.
Robert Valeri C; Ragno G; Veech RL
Transfus Apher Sci; 2008 Dec; 39(3):205-11. PubMed ID: 18951848
[TBL] [Abstract][Full Text] [Related]
16. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery.
Greenburg AG; Kim HW;
J Am Coll Surg; 2004 Mar; 198(3):373-83; discussion 384-5. PubMed ID: 14992738
[TBL] [Abstract][Full Text] [Related]
17. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
[TBL] [Abstract][Full Text] [Related]
18. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery.
Hill SE; Gottschalk LI; Grichnik K
J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):695-702. PubMed ID: 12486649
[TBL] [Abstract][Full Text] [Related]
19. Coagulation patterns following haemoglobin-based oxygen carrier resuscitation in severe uncontrolled haemorrhagic shock in swine.
Arnaud F; Handrigan M; Hammett M; Philbin N; Rice J; Dong F; Pearce LB; McCarron R; Freilich D
Transfus Med; 2006 Aug; 16(4):290-302. PubMed ID: 16879158
[TBL] [Abstract][Full Text] [Related]
20. Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or oxyglobin acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thromboelastography study.
Jahr JS; Weeks DL; Desai P; Lim JC; Butch AW; Gunther R; Driessen B
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):34-9. PubMed ID: 18249328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
